Genetic ancestry, skin reflectance and pigmentation genotypes in association with serum vitamin D metabolite balance

Abstract Background: Lower serum vitamin D (25(OH)D) among individuals with African ancestry is primarily attributed to skin pigmentation. However, the influence of genetic polymorphisms controlling for skin melanin content has not been investigated. Therefore, we investigated differences in non-summer serum vitamin D metabolites according to self-reported race, genetic ancestry, skin reflectance and key pigmentation genes (SLC45A2 and SLC24A5). Materials and methods: Healthy individuals reporting at least half African American or half European American heritage were frequency matched to one another on age (±2 years) and sex. One hundred and seventy-six autosomal ancestry informative markers were used to estimate genetic ancestry. Melanin index was measured by reflectance spectrometry. Serum vitamin D metabolites [25(OH)D3, 25(OH)D2 and 24,25(OH)2D3] were determined by high performance liquid chromatography (HPLC) tandem mass spectrometry. Percent 24,25(OH)2D3 was calculated as a percent of the parent metabolite [25(OH)D3]. Stepwise and backward selection regression models were used to identify leading covariates. Results: Fifty African Americans and 50 European Americans participated in the study. Compared with SLC24A5 111Thr homozygotes, individuals with the SLC24A5 111Thr/Ala and 111Ala/Ala genotypes had, respectively, lower levels of 25(OH)D3 (23.0 and 23.8 nmol/L lower, p-dominant=0.007), and percent 24,25(OH)2D3 (4.1% and 5.2% lower, p-dominant=0.003), controlling for tanning bed use, vitamin D/fish oil supplement intake, race/ethnicity and genetic ancestry. Results were similar with melanin index adjustment, and were not confounded by glucocorticoid, oral contraceptive, or statin use. Conclusions: The SLC24A5 111Ala allele was associated with lower serum vitamin 25(OH)D3 and lower percent 24,25(OH)2D3, independently from melanin index and West African genetic ancestry.

[1]  J. Gallagher,et al.  Relationship between vitamin D, parathyroid hormone, and bone health. , 2011, The Journal of clinical endocrinology and metabolism.

[2]  V. Vaccarino,et al.  Heritability and seasonal variability of vitamin D concentrations in male twins. , 2010, The American journal of clinical nutrition.

[3]  E. Kilpatrick,et al.  Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. , 2010, Clinical chemistry.

[4]  M. Galsky,et al.  Docetaxel-based combination therapy for castration-resistant prostate cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  B. Boyan,et al.  24R,25-Dihydroxyvitamin D3, lysophosphatidic acid, and p53: A signaling axis in the inhibition of phosphate-induced chondrocyte apoptosis , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  Scott M. Williams,et al.  Blood Vitamin D Levels in Relation to Genetic Estimation of African Ancestry , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[7]  L. Declercq,et al.  Structural and functional differences in barrier properties of African American, Caucasian and East Asian skin. , 2010, Journal of dermatological science.

[8]  R. Millikan,et al.  FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. , 2010, Carcinogenesis.

[9]  Ryan E. Forster,et al.  The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  B. Boyan,et al.  24R,25-Dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1α,25(OH)2D3 in hypertrophic cells , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  M. V. Schiaffino Signaling pathways in melanosome biogenesis and pathology. , 2010, The international journal of biochemistry & cell biology.

[12]  H. Morris,et al.  The effect of dietary calcium on 1,25(OH)2D3 synthesis and sparing of serum 25(OH)D3 levels , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  H. Leffers,et al.  Expression of the vitamin D receptor, 25-hydroxylases, 1α-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  R. St-Arnaud CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24 , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  F. Lang,et al.  Regulation of calcium signaling in dendritic cells by 1,25‐dihydroxyvitamin D3 , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  J. Simpson,et al.  Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. , 2010, JAMA.

[17]  William Wheeler,et al.  Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.

[18]  Shosuke Ito,et al.  Predicting Phenotype from Genotype: Normal Pigmentation * , 2010, Journal of forensic sciences.

[19]  K. Dietrich,et al.  Glucocorticoid therapy and risk of bladder cancer , 2009, British Journal of Cancer.

[20]  Chong-K. Kim,et al.  Pharmacokinetics of oral calcitriol in healthy human based on the analysis with an enzyme immunoassay. , 2009, Pharmacological research.

[21]  Kenneth R Feingold,et al.  pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. , 2009, The Journal of investigative dermatology.

[22]  Christoph Lange,et al.  Recovering unused information in genome-wide association studies: the benefit of analyzing SNPs out of Hardy–Weinberg equilibrium , 2009, European Journal of Human Genetics.

[23]  M. Khaled,et al.  αMSH and Cyclic AMP Elevating Agents Control Melanosome pH through a Protein Kinase A-independent Mechanism , 2009, The Journal of Biological Chemistry.

[24]  Wei Chen,et al.  Analysis of cultured human melanocytes based on polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P loci. , 2009, The Journal of investigative dermatology.

[25]  Elizabeth A Yetley,et al.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. , 2008, The American journal of clinical nutrition.

[26]  H. Wulf,et al.  Sunbed Radiation Provokes Cutaneous Vitamin D Synthesis in Humans—A Randomized Controlled Trial , 2008, Photochemistry and photobiology.

[27]  J. Woo,et al.  Very high rates of vitamin D insufficiency in women of child-bearing age living in Beijing and Hong Kong , 2008, British Journal of Nutrition.

[28]  L. Carbone,et al.  25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation. , 2008, Metabolism: clinical and experimental.

[29]  Mark Shriver,et al.  A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications , 2008, Human mutation.

[30]  B. Hammock,et al.  Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometry , 2008, Analytical and bioanalytical chemistry.

[31]  J. Rockell,et al.  Association between quantitative measures of skin color and plasma 25-hydroxyvitamin D , 2008, Osteoporosis International.

[32]  G. Novelli,et al.  Haplotypes in SLC24A5 Gene as Ancestry Informative Markers in Different Populations , 2008, Current genomics.

[33]  G. Costin,et al.  Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. , 2008, Current drug targets.

[34]  Jill S Barnholtz-Sloan,et al.  Ancestry Estimation and Correction for Population Stratification in Molecular Epidemiologic Association Studies , 2008, Cancer Epidemiology Biomarkers & Prevention.

[35]  T. Dadd,et al.  SLC24A5 Encodes a trans-Golgi Network Protein with Potassium-dependent Sodium-Calcium Exchange Activity That Regulates Human Epidermal Melanogenesis* , 2008, Journal of Biological Chemistry.

[36]  D. Cox,et al.  A genomewide association study of skin pigmentation in a South Asian population. , 2007, American journal of human genetics.

[37]  David Moher,et al.  Effectiveness and safety of vitamin D in relation to bone health. , 2007, Evidence report/technology assessment.

[38]  M. Holick,et al.  Factors that influence the cutaneous synthesis and dietary sources of vitamin D. , 2007, Archives of biochemistry and biophysics.

[39]  P. Schnetkamp,et al.  Structure–Function Relationships of the NCKX2 Na+/Ca2+‐K+ Exchanger , 2007, Annals of the New York Academy of Sciences.

[40]  R. Kittles,et al.  Genetic evidence for the convergent evolution of light skin in Europeans and East Asians. , 2006, Molecular biology and evolution.

[41]  B. Henderson,et al.  Racial/Ethnic Differences in Postmenopausal Endogenous Hormones: The Multiethnic Cohort Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[42]  R. Wallace,et al.  Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical, cognitive, and socioeconomic indicators. , 2006, American journal of public health.

[43]  B. Genge,et al.  Effects of 24R,25‐ and 1α,25‐dihydroxyvitamin D3 on mineralizing growth plate chondrocytes , 2006, Journal of cellular biochemistry.

[44]  B. Segmuller,et al.  Degradation chemistry of a Vitamin D analogue (ecalcidene) investigated by HPLC-MS, HPLC-NMR and chemical derivatization. , 2006, Journal of pharmaceutical and biomedical analysis.

[45]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.

[46]  H. Boshuizen,et al.  Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[47]  Keith C. Cheng,et al.  SLC24A5, a Putative Cation Exchanger, Affects Pigmentation in Zebrafish and Humans , 2005, Science.

[48]  S. Hankinson,et al.  Racial Differences in Premenopausal Endogenous Hormones , 2005, Cancer Epidemiology Biomarkers & Prevention.

[49]  Glenville Jones,et al.  Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.

[50]  B. Fuller,et al.  The relationship between Na(+)/H(+) exchanger expression and tyrosinase activity in human melanocytes. , 2004, Experimental cell research.

[51]  Jeffrey B. Cheng,et al.  Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Scott M. Williams,et al.  A high-density admixture map for disease gene discovery in african americans. , 2004, American journal of human genetics.

[53]  M. Cogswell,et al.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.

[54]  P. Vestergaard,et al.  Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized‐controlled study on the effects of loop‐ and thiazide‐diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women , 2001, European journal of clinical investigation.

[55]  S. Cummings,et al.  A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. , 2001, The Journal of clinical endocrinology and metabolism.

[56]  B. Fuller,et al.  Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. , 2001, Experimental cell research.

[57]  P. Clarys,et al.  Skin color measurements: comparison between three instruments: the Chromameter®, the DermaSpectrometer® and the Mexameter® , 2000, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[58]  M. Brilliant,et al.  Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes. , 2000, The Journal of investigative dermatology.

[59]  F. Glorieux,et al.  Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. , 2000, Endocrinology.

[60]  S. Fukushima,et al.  Chemopreventive effect of 24R,25-dihydroxyvitamin D(3) in N, N'-dimethylhydrazine-induced rat colon carcinogenesis. , 2000, Carcinogenesis.

[61]  B. Dawson-Hughes,et al.  Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. , 1998, The American journal of clinical nutrition.

[62]  F. Muskiet,et al.  Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose , 1998, British Journal of Nutrition.

[63]  F. Glorieux,et al.  The 25‐Hydroxyvitamin D 1‐Alpha‐Hydroxylase Gene Maps to the Pseudovitamin D‐Deficiency Rickets (PDDR) Disease Locus , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[64]  A. Norman,et al.  Three‐Fold Induction of Renal 25‐Hydroxyvitamin D3‐24‐Hydroxylase Activity and Increased Serum 24,25‐Dihydroxyvitamin D3 Levels Are Correlated with the Healing Process After Chick Tibial Fracture , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[65]  P. Elias,et al.  Skin type, but neither race nor gender, influence epidermal permeability barrier function. , 1995, Archives of dermatology.

[66]  R. Marks,et al.  The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. , 1995, Archives of dermatology.

[67]  H. DeLuca,et al.  Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[68]  R. Marcus,et al.  90300684 Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women , 1991 .

[69]  J. Zerwekh,et al.  Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism. , 1989, The Journal of clinical endocrinology and metabolism.

[70]  L. Lin,et al.  A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.

[71]  T. Fitzpatrick The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of dermatology.

[72]  B. Specker,et al.  Serial ultraviolet B exposure and serum 25 hydroxyvitamin D response in young adult American blacks and whites: no racial differences. , 1988, Journal of the American College of Nutrition.

[73]  R. Globus,et al.  Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate. , 1986, The Journal of clinical investigation.

[74]  A. Norman,et al.  Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. , 1985, Mineral and electrolyte metabolism.

[75]  C. Ainley,et al.  Biliary excretion of radioactivity after intravenous administration of 3H-1,25-dihydroxyvitamin D3 in man. , 1985, Digestive diseases and sciences.

[76]  M. Holick,et al.  Aging decreases the capacity of human skin to produce vitamin D3. , 1985, The Journal of clinical investigation.

[77]  R. Turner,et al.  Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. , 1984, The Journal of clinical investigation.

[78]  B. Hollis,et al.  Defective photoproduction of cholecalciferol in normal and uremic humans. , 1984, The Journal of nutrition.

[79]  T. Kuroki,et al.  Regulation of Terminal Differentiation of Cultured Mouse Epidermal Cells by lα,25-Dihydroxyvitamin D3 , 1983 .

[80]  A. Norman,et al.  Evidence for circadian rhythms in the serum levels of the vitamin D‐dependent calcium‐binding protein and in the activity of the 25‐hydroxyvitamin D3‐1‐α‐hydroxylase in the chick , 1982, FEBS letters.

[81]  J. Adams,et al.  INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.

[82]  M. Holick,et al.  The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. , 1981, The Journal of investigative dermatology.

[83]  J. Bourgoignie,et al.  Metabolic consequences of oral administration of 24,25-dihydroxycholecalciferol to uremic dogs. , 1980, The Journal of clinical investigation.

[84]  A. Norman,et al.  Studies on the metabolism of calciferol. XIV: Evidence of a circadian rhythm in the activity of the 25-hydroxyvitamin D3-1-hydroxylase. , 1979, Biochemical and biophysical research communications.

[85]  M. Haussler,et al.  Influence of estrogen on renal vitamin D hydroxylases and serum 1alpha,25-(OH)2D3 in chicks. , 1978, The American journal of physiology.

[86]  H. DeLuca,et al.  1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. , 1973, The Journal of biological chemistry.

[87]  I. Macintyre Vitamin D metabolism. , 1973, The New England journal of medicine.

[88]  B. Hollis Detection of Vitamin D and Its Major Metabolites , 2011 .

[89]  Christine L. Taylor,et al.  Committee to Review Dietary Reference Intakes for Vitamin D and Calcium , 2011 .

[90]  M. Holick,et al.  Photobiology of Vitamin D , 2010 .

[91]  G. Cairano,et al.  Effect of the administration of 1,25-dihydroxyvitamin D3 on serum levels of 25-hydroxyvitamin D in postmenopausal osteoporosis , 2006, Calcified Tissue International.

[92]  D. Bikle CHAPTER 35 – Vitamin D: Role in Skin and Hair , 2005 .

[93]  M. Itoh,et al.  Seasonal changes of serum 25-hydroxyvitamin D and intact parathyroid hormone levels in a normal Japanese population , 2004, Journal of Bone and Mineral Metabolism.

[94]  M. Holick,et al.  Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.

[95]  Z. Varghese,et al.  Effect of 24,25-dihydroxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure. , 1992, Nephron.

[96]  J. Kanis,et al.  Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in man. , 1978, Advances in experimental medicine and biology.

[97]  M. Peacock,et al.  Proceedings: Inhibitory effect of 24,25-dihydroxycholecalciferol on parathyroid hormone secretion in the goat. , 1975, The Journal of endocrinology.

[98]  E. Mawer,et al.  The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition. , 1971, Clinical science.